Vascular Medicine

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Sign In to gain access to subscriptions and/or personal tools.
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Regensteiner, J. G
Right arrow Articles by Weil, J. V
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Regensteiner, J. G
Right arrow Articles by Weil, J. V
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
Vascular Medicine, Vol. 8, No. 3, 169-175 (2003)
DOI: 10.1191/1358863x03vm489oa

Oral L-arginine and vitamins E and C improve endothelial function in women with type 2 diabetes

Judith G Regensteiner

Department of Medicine, Division of Internal Medicine, University of Colorado Health Sciences Center, Denver, CO, USA, Department of Medicine, Division of Cardiology, University of Colorado Health Sciences Center, Denver, CO, USA, judy.regensteiner{at}uchsc.edu

Shawn Popylisen

Department of Medicine, Division of Cardiology, University of Colorado Health Sciences Center, Denver, CO, USA

Timothy A Bauer

Department of Medicine, Division of Cardiology, University of Colorado Health Sciences Center, Denver, CO, USA

JoAnn Lindenfeld

Department of Medicine, Division of Cardiology, University of Colorado Health Sciences Center, Denver, CO, USA

Edward Gill

Department of Medicine, Division of Cardiology, University of Colorado Health Sciences Center, Denver, CO, USA

Susan Smith

Department of Medicine, Division of Internal Medicine, University of Colorado Health Sciences Center, Denver, CO, USA

Cheryl K Oliver-Pickett

Department of Medicine, Division of Cardiology, University of Colorado Health Sciences Center, Denver, CO, USA

Jane EB Reusch

Department of Medicine, Division of Endocrinology, University of Colorado Health Sciences Center, Denver, CO, USA

John V Weil

Department of Medicine, Division of Cardiology, University of Colorado Health Sciences Center, Denver, CO, USA

Endothelial dilator function is impaired in people with type 2 diabetes mellitus (T2DM). Prior research indicates that this can be improved with intravenous administration of ascorbate or L-arginine, but whether these agents have this effect when administered by the clinically practical oral route is unknown. To investigate this question, 10 premenopausal women with T2DM and 10 healthy, premenopausal, non-diabetic women received, in random sequence, a 1-week administration of oral L-arginine (9 g daily) or vitamins E (1800 mg) and C (1000 mg) with an intervening 1-week washout period. Flow-mediated brachial artery dilation (FMD) was measured by ultrasonography and forearm blood flow was measured by plethysmography before and following blood pressure cuff-induced forearm ischemia before and after each week of treatment. At baseline, the women with T2DM had lesser FMD responses (0.028 ± 0.006 cm vs 0.056 ± 0.008 cm, p, 0.05). Post-ischemic forearm hyperemia was reduced at baseline in T2DM compared with controls (16.4 ± 1.8 vs 26.0 ± 1.4 ml 100 ml-1 min-1, p <0.05). Administration of L-arginine caused a 50 ± 12% increase in FMD in T2DM (p < 0.05) and raised post-ischemic forearm blood flow by 29 ± 8% (p < 0.05). No significant changes were seen in controls. Administration of vitamins E and C in women with T2DM produced an increase in the brachial artery diameter response of 79 ± 15% (p < 0.05), but did not significantly increase the hyperemic blood flow response (p = NS). No significant changes in the responses of controls from pre to post vitamin administration were observed. We concluded that administration of two types of oral agents improved measures of endothelial function in people with T2DM.

Key Words: antioxidant vitamins • diabetes • endothelial function • L-arginine


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Diabetes CareHome page
T. A. Bauer, J. E.B. Reusch, M. Levi, and J. G. Regensteiner
Skeletal Muscle Deoxygenation After the Onset of Moderate Exercise Suggests Slowed Microvascular Blood Flow Kinetics in Type 2 Diabetes
Diabetes Care, November 1, 2007; 30(11): 2880 - 2885.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
D. J. Padilla, P. McDonough, B. J. Behnke, Y. Kano, K. S. Hageman, T. I. Musch, and D. C. Poole
Effects of Type II diabetes on capillary hemodynamics in skeletal muscle
Am J Physiol Heart Circ Physiol, November 1, 2006; 291(5): H2439 - H2444.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
H. Chen, R. J. Karne, G. Hall, U. Campia, J. A. Panza, R. O. Cannon III, Y. Wang, A. Katz, M. Levine, and M. J. Quon
High-dose oral vitamin C partially replenishes vitamin C levels in patients with Type 2 diabetes and low vitamin C levels but does not improve endothelial dysfunction or insulin resistance
Am J Physiol Heart Circ Physiol, January 1, 2006; 290(1): H137 - H145.
[Abstract] [Full Text] [PDF]


Home page
Diabetes CareHome page
J. G. Regensteiner, T. A. Bauer, and J. E.B. Reusch
Rosiglitazone Improves Exercise Capacity in Individuals With Type 2 Diabetes
Diabetes Care, December 1, 2005; 28(12): 2877 - 2883.
[Abstract] [Full Text] [PDF]